BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27261521)

  • 1. Parametric Binding Images of the TSPO Ligand 18F-DPA-714.
    Golla SS; Boellaard R; Oikonen V; Hoffmann A; van Berckel BN; Windhorst AD; Virta J; Te Beek ET; Groeneveld GJ; Haaparanta-Solin M; Luoto P; Savisto N; Solin O; Valencia R; Thiele A; Eriksson J; Schuit RC; Lammertsma AA; Rinne JO
    J Nucl Med; 2016 Oct; 57(10):1543-1547. PubMed ID: 27261521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients.
    Golla SS; Boellaard R; Oikonen V; Hoffmann A; van Berckel BN; Windhorst AD; Virta J; Haaparanta-Solin M; Luoto P; Savisto N; Solin O; Valencia R; Thiele A; Eriksson J; Schuit RC; Lammertsma AA; Rinne JO
    J Cereb Blood Flow Metab; 2015 May; 35(5):766-72. PubMed ID: 25649991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
    Lavisse S; García-Lorenzo D; Peyronneau MA; Bodini B; Thiriez C; Kuhnast B; Comtat C; Remy P; Stankoff B; Bottlaender M
    J Nucl Med; 2015 Jul; 56(7):1048-54. PubMed ID: 26025960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
    J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation.
    Chauveau F; Van Camp N; Dollé F; Kuhnast B; Hinnen F; Damont A; Boutin H; James M; Kassiou M; Tavitian B
    J Nucl Med; 2009 Mar; 50(3):468-76. PubMed ID: 19223401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.
    Tang D; Hight MR; McKinley ET; Fu A; Buck JR; Smith RA; Tantawy MN; Peterson TE; Colvin DC; Ansari MS; Nickels M; Manning HC
    J Nucl Med; 2012 Feb; 53(2):287-94. PubMed ID: 22251555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation and Quantification of
    Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
    J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation.
    Arlicot N; Vercouillie J; Ribeiro MJ; Tauber C; Venel Y; Baulieu JL; Maia S; Corcia P; Stabin MG; Reynolds A; Kassiou M; Guilloteau D
    Nucl Med Biol; 2012 May; 39(4):570-8. PubMed ID: 22172392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of methods for generating parametric (R-[11C]PK11195 binding images.
    Schuitemaker A; van Berckel BN; Kropholler MA; Kloet RW; Jonker C; Scheltens P; Lammertsma AA; Boellaard R
    J Cereb Blood Flow Metab; 2007 Sep; 27(9):1603-15. PubMed ID: 17311080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.
    Ory D; Postnov A; Koole M; Celen S; de Laat B; Verbruggen A; Van Laere K; Bormans G; Casteels C
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):163-172. PubMed ID: 26323575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET.
    Vicidomini C; Panico M; Greco A; Gargiulo S; Coda AR; Zannetti A; Gramanzini M; Roviello GN; Quarantelli M; Alfano B; Tavitian B; Dollé F; Salvatore M; Brunetti A; Pappatà S
    Nucl Med Biol; 2015 Mar; 42(3):309-16. PubMed ID: 25537727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeatability of parametric methods for [
    Verfaillie SC; Golla SS; Timmers T; Tuncel H; van der Weijden CW; Schober P; Schuit RC; van der Flier WM; Windhorst AD; Lammertsma AA; van Berckel BN; Boellaard R
    J Cereb Blood Flow Metab; 2021 Mar; 41(3):569-578. PubMed ID: 32321347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Endothelial 18-kDa Translocator Protein on the Quantification of
    Wimberley C; Lavisse S; Brulon V; Peyronneau MA; Leroy C; Bodini B; Remy P; Stankoff B; Buvat I; Bottlaender M
    J Nucl Med; 2018 Feb; 59(2):307-314. PubMed ID: 28775204
    [No Abstract]   [Full Text] [Related]  

  • 14. The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.
    Winkeler A; Boisgard R; Awde AR; Dubois A; Thézé B; Zheng J; Ciobanu L; Dollé F; Viel T; Jacobs AH; Tavitian B
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):811-23. PubMed ID: 22270507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein.
    Lyoo CH; Ikawa M; Liow JS; Zoghbi SS; Morse CL; Pike VW; Fujita M; Innis RB; Kreisl WC
    J Nucl Med; 2015 May; 56(5):701-6. PubMed ID: 25766898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro characterization of novel fluorinated derivatives of the translocator protein 18 kDa ligand CfO-DPA-714.
    Cacheux F; Médran-Navarrete V; Dollé F; Marguet F; Puech F; Damont A
    Eur J Med Chem; 2017 Jan; 125():346-359. PubMed ID: 27688189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F]DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain.
    Lavisse S; Inoue K; Jan C; Peyronneau MA; Petit F; Goutal S; Dauguet J; Guillermier M; Dollé F; Rbah-Vidal L; Van Camp N; Aron-Badin R; Remy P; Hantraye P
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):478-94. PubMed ID: 25488184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of parametric methods for [¹¹C]PE2I positron emission tomography.
    Jonasson M; Appel L; Engman J; Frick A; Nyholm D; Askmark H; Danfors T; Sörensen J; Furmark T; Lubberink M
    Neuroimage; 2013 Jul; 74():172-8. PubMed ID: 23435214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.
    Heurling K; Buckley C; Van Laere K; Vandenberghe R; Lubberink M
    Neuroimage; 2015 Nov; 121():184-92. PubMed ID: 26209803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.
    Baker SL; Lockhart SN; Price JC; He M; Huesman RH; Schonhaut D; Faria J; Rabinovici G; Jagust WJ
    J Nucl Med; 2017 Feb; 58(2):332-338. PubMed ID: 27587706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.